Bienville Capital Management’s Cardlytics CDLX Stock Holding History

Bienville Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-729	Closed	-$482K	–	145
2021 Q4	$482K	Hold	729	–	–	0.35%	57
2021 Q3	$612K	Hold	729	–	–	0.35%	49
2021 Q2	$926K	Hold	729	–	–	0.08%	71
2021 Q1	$800K	Hold	729	–	–	0.1%	71
2020 Q4	$1.04M	Sell	729 -8,665	-92%	-$9.24M	0.11%	55
2020 Q3	$6.63M	Sell	9,394 -9,980	-52%	-$7.26M	0.75%	22
2020 Q2	$13.6M	Buy	+19,374	New	+$11.2M	1.26%	10

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

JCM

JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return

Bienville Capital Management's CDLX Position: Q1 2022 in Review

Bienville Capital Management sold out of Cardlytics (CDLX) in Q1 2022, closing a stake of 729 shares — an estimated $482K sold.

Bienville Capital Management first reported a position in CDLX in Q2 2020 and held it in 7 quarters. The position peaked at $13.6M in Q2 2020. 153 funds tracked by Wall St. Rank hold CDLX as of Q1 2022.

Bienville Capital Management reported no remaining Cardlytics position as of Q1 2022 after selling out during the quarter.
Bienville Capital Management sold 729 Cardlytics shares in Q1 2022, an estimated $482K.
Bienville Capital Management first reported a position in Cardlytics in Q2 2020 and held it in 7 quarters.
Bienville Capital Management's Cardlytics position peaked at $13.6M in Q2 2020.
153 funds tracked by Wall St. Rank held Cardlytics as of Q1 2022.

Based on Bienville Capital Management's 13F filing for Q1 2022, filed 16 May 2022.